Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Meador CB"'
Autor:
Meador CB; Massachusetts General Hospital, Boston, United States., Digumarthy SR; Massachusetts General Hospital, Boston, MA, United States., Yeap BY; Massachusetts General Hospital, Boston, MA, United States., Hung YP; Massachusetts General Hospital, Boston, United States., Mino-Kenudson M; Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States., Farago AF; Massachusetts General Hospital, Boston, MA, United States., Heist RS; Massachusetts General Hospital, Boston, MA, United States., Marcoux JP; Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, United States., Rangachari D; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Barbie DA; Dana-Farber Cancer Institute, Boston, MA, United States., Piotrowska Z; Massachusetts General Hospital, Boston, Massachusetts, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 29. Date of Electronic Publication: 2024 Oct 29.
Autor:
El Zarif T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut., Meador CB; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Qiu X; Department of Medicine, Yale School of Medicine, New Haven, Connecticut., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Davidsohn MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Lakshminarayanan G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., McClure HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Canniff J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Fortunato B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Li R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Banwait MK; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Eli and Edythe L. Broad Institute, Cambridge, Massachusetts., Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Long H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Hung YP; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Piotrowska Z; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Eli and Edythe L. Broad Institute, Cambridge, Massachusetts., Hata AN; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Eli and Edythe L. Broad Institute, Cambridge, Massachusetts., Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 03; Vol. 30 (17), pp. 3798-3811.
Autor:
Murayama T; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Meador CB; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Ivanova EV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Pan Y; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Knelson EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tani T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nakayama J; Department of Oncogenesis and Growth Regulation, Osaka International Cancer Institute, Osaka, Japan.; Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan., Ma X; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hung YP; Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Kim W; Moores Cancer Center, UC San Diego, La Jolla, California.; Center for Novel Therapeutics, UC San Diego, La Jolla, California.; Department of Medicine, UC San Diego, La Jolla, California., Watanabe H; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Cai KQ; Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Hata AN; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cañadas I; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Sep 01; Vol. 4 (9), pp. 2399-2414.
Autor:
Pal Choudhuri S; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Girard L; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas., Lim JYS; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas., Wise JF; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Freitas B; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Yang D; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Wong E; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts., Hamilton S; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Chien VD; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Kim YJ; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas., Gilbreath C; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas., Zhong J; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts., Phat S; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts., Myers DT; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts., Christensen CL; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Mazloom-Farsibaf H; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas., Stanzione M; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts., Wong KK; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Hung YP; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Farago AF; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts., Meador CB; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts., Dyson NJ; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts., Lawrence MS; Massachusetts General Hospital Cancer Center, Krantz Family Center for Cancer Research, Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Wu S; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas., Drapkin BJ; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 May 01; Vol. 14 (5), pp. 804-827.
Autor:
Chen JH; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA. jhchen@broadinstitute.org.; Department of Pathology, MGH, Boston, MA, USA. jhchen@broadinstitute.org.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. jhchen@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. jhchen@broadinstitute.org., Nieman LT; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Spurrell M; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Department of Pathology, MGH, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Jorgji V; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Department of Pathology, MGH, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Elmelech L; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Department of Pathology, MGH, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Richieri P; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA., Xu KH; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA., Madhu R; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Division of Genetics, Boston, MA, USA., Parikh M; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Zamora I; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Mehta A; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Nabel CS; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Koch Institute for Integrative Cancer Research, Department of Biology, MIT, Cambridge, MA, USA., Freeman SS; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Pirl JD; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Lu C; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA., Meador CB; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Division of Hematology/Oncology, MGH, HMS, Boston, MA, USA., Barth JL; Department of Pathology, MGH, Boston, MA, USA., Sakhi M; Center for Thoracic Cancers, MGH, Boston, MA, USA., Tang AL; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Sarkizova S; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Price C; Vizgen, Cambridge, MA, USA., Fernandez NF; Vizgen, Cambridge, MA, USA., Emanuel G; Vizgen, Cambridge, MA, USA., He J; Vizgen, Cambridge, MA, USA., Van Raay K; NanoString Technologies, Seattle, WA, USA., Reeves JW; NanoString Technologies, Seattle, WA, USA., Yizhak K; Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Hofree M; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.; Lautenberg Center for Immunology and Cancer Research, The Hebrew University of Jerusalem, Jerusalem, Israel., Shih A; Department of Pathology, MGH, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Sade-Feldman M; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Boland GM; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Surgery, MGH, Boston, MA, USA., Pelka K; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Gladstone-UCSF Institute of Genomic Immunology, Gladstone Institutes, San Francisco, CA, USA., Aryee MJ; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Mino-Kenudson M; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.; Department of Pathology, MGH, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Gainor JF; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA. jgainor@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. jgainor@mgh.harvard.edu.; Center for Thoracic Cancers, MGH, Boston, MA, USA. jgainor@mgh.harvard.edu., Korsunsky I; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. ikorsunsky@bwh.harvard.edu.; Harvard Medical School, Boston, MA, USA. ikorsunsky@bwh.harvard.edu.; Brigham and Women's Hospital, Division of Genetics, Boston, MA, USA. ikorsunsky@bwh.harvard.edu., Hacohen N; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA. nhacohen@mgh.harvard.edu.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. nhacohen@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. nhacohen@mgh.harvard.edu.
Publikováno v:
Nature immunology [Nat Immunol] 2024 Apr; Vol. 25 (4), pp. 644-658. Date of Electronic Publication: 2024 Mar 19.
Autor:
Denize T; Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Meador CB; Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Rider AB; Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Ganci ML; Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Barth JL; Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Kem M; Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Mino-Kenudson M; Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Hung YP; Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
Publikováno v:
Histopathology [Histopathology] 2023 Dec; Vol. 83 (6), pp. 912-924. Date of Electronic Publication: 2023 Aug 29.
Autor:
Mansur A; Harvard Medical School, Boston, Massachusetts; Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts., Potter AL; Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts; University of California Berkeley, Berkeley, California., Nees AT; Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts; University of California, Santa Barbara, California., Sands JM; Dana-Farber Cancer Institute, Boston, Massachusetts., Meador CB; Massachusetts General Cancer Center, Boston, Massachusetts., Fong ZV; Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts., Auchincloss HG; Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts., Yang CJ; Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: cjyang@mgh.harvard.edu.
Publikováno v:
The Annals of thoracic surgery [Ann Thorac Surg] 2023 Dec; Vol. 116 (6), pp. 1142-1148. Date of Electronic Publication: 2023 May 26.
Autor:
Qian Y; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA., Galan-Cobo A; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA., Guijarro I; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA., Dang M; Department of Genomic Medicine, Houston, TX, USA., Molkentine D; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA., Poteete A; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA., Zhang F; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA., Wang Q; Department of Bioinformatics and Computational Biology, Houston, TX, USA., Wang J; Department of Bioinformatics and Computational Biology, Houston, TX, USA., Parra E; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Panda A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Fang J; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Skoulidis F; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Verma S; Ludwig Collaborative and Swim Across America Laboratory, MSK, New York, NY, USA., Merghoub T; Ludwig Collaborative and Swim Across America Laboratory, MSK, New York, NY, USA., Wolchok JD; Ludwig Collaborative and Swim Across America Laboratory, MSK, New York, NY, USA., Wong KK; Division of Hematology & Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA., DeBerardinis RJ; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA., Minna JD; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, USA., Vokes NI; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA., Meador CB; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA; Center for Thoracic Cancers, Massachusetts General Hospital, Boston, MA, USA., Gainor JF; Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Center for Thoracic Cancers, Massachusetts General Hospital, Boston, MA, USA., Wang L; Department of Genomic Medicine, Houston, TX, USA., Reuben A; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA., Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, Houston, TX, USA. Electronic address: jheymach@mdanderson.org.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Jul 10; Vol. 41 (7), pp. 1363-1380.e7. Date of Electronic Publication: 2023 Jun 15.
Autor:
Meador CB; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA., Gainor JF; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA. Electronic address: jgainor@mgh.harvard.edu.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2023 Jul; Vol. 24 (5), pp. e162-e163. Date of Electronic Publication: 2023 Mar 21.
Autor:
Choudhuri SP, Girard L, Lim JYS, Wise JF, Freitas B, Yang D, Wong E, Hamilton S, Chien VD, Gilbreath C, Zhong J, Phat S, Myers DT, Christensen CL, Stanzione M, Wong KK, Farago AF, Meador CB, Dyson NJ, Lawrence MS, Wu S, Drapkin BJ
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Jun 28. Date of Electronic Publication: 2023 Jun 28.